Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 5:03 AM ET


Company Overview of Bicycle Therapeutics Limited

Company Overview

Bicycle Therapeutics Limited, a biotherapeutics company, focuses on developing highly constrained bicyclic peptides (bicycles) as novel class of therapeutics. The company is involved in developing a pipeline of bicycle molecules by using its proprietary bicyclic peptide technology that provide antibody-like affinity and selectivity in a much smaller chemically synthesized molecule. It applies its technology to various drug discovery projects, including oncology, ophthalmology, and other therapeutic areas through collaborative discovery partnerships with pharmaceutical companies. Bicycle Therapeutics Limited was founded in 2009 and is based in Cambridge, United Kingdom.

Meditrina Building

Babraham Research Campus

Cambridge,  CB22 3AT

United Kingdom

Founded in 2009


44 1223 497 415

Key Executives for Bicycle Therapeutics Limited

Chief Executive Officer
President and Chief Business Officer
Age: 52
Executive Chairman
Scientific Founder
Co-Founder, Director and Member of Scientific Advisory Board
Age: 64
Compensation as of Fiscal Year 2015.

Bicycle Therapeutics Limited Key Developments

Bicycle Therapeutics Limited Presents at BIO-Europe 2015, Nov-02-2015

Bicycle Therapeutics Limited Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Bicycle Therapeutics Limited Announces Appointment of Kevin Lee as Chief Executive Officer

Bicycle Therapeutics Limited announced the appointment of Kevin Lee, Ph.D., as Chief Executive Officer. Dr. Lee brings more than 20 years of experience in drug discovery and development leadership, most recently from Pfizer, spanning the pharmaceutical and biotechnology industries as well as academia.

Bicycle Therapeutics Limited Appoints Arvind Hundal as a President & Chief Business Officer

Bicycle Therapeutics Limited appointed Arvind Hundal as President & Chief Business Officer. Dr. Hundal has more than 20 years experience in the life sciences sector, the majority of which have been in business development and strategy roles. She was most recently Chief Business Officer and Senior Management Team Member of Zealand Pharma A/S and was a part of the team that lead the successful initial public offering in 2010. Dr. Hundal has a broad range of relevant expertise including working in oncology with phage display and peptides, and has held strategic and transactional business development roles at PREACIS Pharmaceuticals, Xcellsyz, Albireo, Roche and AstraZeneca.

Similar Private Companies By Industry

Company Name Region
OncoLytika Ltd Europe
Scancell Limited Europe
United Therapeutics Europe, Ltd. Europe
EvoCell Ltd. Europe
pSiMedica Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bicycle Therapeutics Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at